About 1 result found for searched term "Epratuzumab" (0.139 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24897 | Epratuzumab | Others |
| Antibody hLL 2 Anti-Human CD22 Recombinant Antibody | ||
| Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
